Trial Profile
A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2008
Price :
$35
*
At a glance
- Drugs ABT 751 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 28 Nov 2007 Status change from in progress to completed
- 25 Sep 2005 New trial record.